However, in addition to determining which other conditions to seek in a patient who carries the MEN1 gene, there is emerging evidence that genotype may impact to an extent on the aggressiveness of the pancreatic NETs [8–10]. The gene discussed is MEN1; the disease is pancreatic neuroendocrine tumor.